Literature DB >> 8143605

The HPRT short-term assay in monitoring individuals exposed to genotoxic agents.

R Montero1, M E Gonsebatt, L A Herrera, E Rojas, P Ostrosky-Wegman.   

Abstract

This paper reviews several monitoring studies where the short-term HPRT assay has been applied. The original method uses autoradiography to detect 3H-thymidine incorporation in variant cells that have undergone DNA synthesis; the bromodeoxyuridine modification employs this thymidine analog and fluorescence plus Giemsa staining. The studies discussed here were accomplished with either of these methods. methods. Exposures analyzed include radiation and chemotherapy as medical treatments and accidental exposures to radiation; these studies have been useful in the validation of the assay because radiation and anticancer drugs are well-known mutagens. Other potential mutagens such as environmental arsenic and a parasitic infection and praziquantel, used for its treatment, have also been monitored for hprt locus mutation. An overview of the results obtained with different agents and routes of exposure is presented here as well as some methodological aspects for the optimization of the assay for monitoring studies.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8143605      PMCID: PMC1521115          DOI: 10.1289/ehp.93101s3135

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  13 in total

Review 1.  In vivo somatic mutations in humans: measurement and analysis.

Authors:  R J Albertini; J A Nicklas; J P O'Neill; S H Robison
Journal:  Annu Rev Genet       Date:  1990       Impact factor: 16.830

2.  Increased frequency of 6-thioguanine-resistant lymphocytes in peripheral blood of workers employed in cyclophosphamide production.

Authors:  E Hüttner; U Mergner; R Braun; J Schöneich
Journal:  Mutat Res       Date:  1990-02       Impact factor: 2.433

3.  Determination of 6-thioguanine resistant lymphocytes in human blood by immunohistochemical antibromodeoxyuridine staining.

Authors:  R Montero; H Norppa; K Autio; C Lindholm; P Ostrosky-Wegman; M Sorsa
Journal:  Mutagenesis       Date:  1991-03       Impact factor: 3.000

4.  Elevated frequencies of 6-thioguanine-resistant lymphocytes in multiple sclerosis patients treated with cyclophosphamide: a prospective study.

Authors:  M M Ammenheuser; J B Ward; E B Whorton; J M Killian; M S Legator
Journal:  Mutat Res       Date:  1988-03       Impact factor: 2.433

Review 5.  Is environmental carcinogenesis modulated by host polymorphism?

Authors:  J R Idle
Journal:  Mutat Res       Date:  1991-04       Impact factor: 2.433

6.  6-Thioguanine-resistant T-lymphocyte autoradiographic assay. Determination of variation frequencies in individuals suspected of radiation exposure.

Authors:  P Ostrosky-Wegman; R Montero; A Palao; C Cortinas de Nava; F Hurtado; R J Albertini
Journal:  Mutat Res       Date:  1990-09       Impact factor: 2.433

7.  The use of bromodeoxyuridine labeling in the human lymphocyte HGPRT somatic mutation assay.

Authors:  P Ostrosky-Wegman; M R Montero; C C de Nava; R R Tice; R Albertini
Journal:  Mutat Res       Date:  1987 Jul-Aug       Impact factor: 2.433

Review 8.  Relevance of metabolic polymorphisms to human carcinogenesis: evaluation of epidemiologic evidence.

Authors:  N Caporaso; M T Landi; P Vineis
Journal:  Pharmacogenetics       Date:  1991-10

9.  Somatic gene mutations in vivo as indicated by the 6-thioguanine-resistant T-lymphocytes in human blood.

Authors:  R J Albertini
Journal:  Mutat Res       Date:  1985 Jun-Jul       Impact factor: 2.433

10.  Enumeration of 6-thioguanine-resistant peripheral blood lymphocytes in man as a potential test for somatic cell mutations arising in vivo.

Authors:  G H Strauss; R J Albertini
Journal:  Mutat Res       Date:  1979-07       Impact factor: 2.433

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.